Detalles de la búsqueda
1.
Advancing Patient-Centered Care: An International Survey of Adolescent Perspectives on Insomnia.
Behav Sleep Med
; : 1-22, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38488114
2.
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
Alzheimers Dement
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38779814
3.
Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
Neurobiol Dis
; 162: 105563, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838668
4.
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Hum Mol Genet
; 27(16): 2893-2912, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860333
5.
Receptor dependence of BDNF actions in superficial dorsal horn: relation to central sensitization and actions of macrophage colony stimulating factor 1.
J Neurophysiol
; 121(6): 2308-2322, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30995156
6.
A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
Hum Mol Genet
; 25(22): 4920-4938, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28171570
7.
A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
J Neurosci
; 33(48): 18712-27, 2013 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24285878
8.
Pharmacological Co-Activation of TrkB and TrkC Receptor Signaling Ameliorates Striatal Neuropathology and Motor Deficits in Mouse Models of Huntington's Disease.
J Huntingtons Dis
; 12(3): 215-239, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37638447
9.
Factors affecting pediatric adherence to positive airway pressure: Patient- and caregiver-reported treatment barriers and sleep difficulties.
Sleep Med
; 101: 58-65, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335892
10.
Current Considerations in the Diagnosis and Treatment of Circadian Rhythm Sleep-Wake Disorders in Children.
Semin Pediatr Neurol
; 48: 101091, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065634
11.
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
bioRxiv
; 2023 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781573
12.
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.
Proc Natl Acad Sci U S A
; 106(12): 4906-11, 2009 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-19264961
13.
Relationship of overweight and obesity to insomnia severity, sleep quality, and insomnia improvement in a clinically referred pediatric sample.
J Clin Sleep Med
; 18(4): 1083-1091, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879901
14.
Structural basis of fatty acid substrate binding to cyclooxygenase-2.
J Biol Chem
; 285(29): 22152-63, 2010 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20463020
15.
Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice.
Neurobiol Dis
; 41(2): 436-44, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20977939
16.
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31.
Neurotherapeutics
; 18(2): 1039-1063, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33786806
17.
Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.
J Biol Chem
; 284(43): 29427-36, 2009 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-19710014
18.
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Mol Cell Neurosci
; 39(1): 8-20, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18602275
19.
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
Mol Cell Neurosci
; 39(1): 1-7, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18571429
20.
Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation.
Radiother Oncol
; 139: 4-10, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31253467